1 | moderate | 21,087 |
2 | 5/200 | 16 |
3 | medium/high | 15 |
4 | moderate-level | 12 |
5 | moderately-severe | 11 |
6 | lancinating | 8 |
7 | 15μm | 6 |
8 | allevyn™ | 6 |
9 | t4lhyp | 6 |
10 | hyposmic | 5 |
11 | t3a | 5 |
12 | very-low- | 5 |
13 | high-moderate | 4 |
14 | ni2+ | 4 |
15 | pheromonal | 4 |
16 | troncular | 4 |
17 | 0.4±0.8 | 3 |
18 | as≥3 | 3 |
19 | batyl | 3 |
20 | cyca | 3 |
21 | difficult-to-revert | 3 |
22 | franc | 3 |
23 | moderate-to-light | 3 |
24 | neuroimage | 3 |
25 | one-grade | 3 |
26 | over-response | 3 |
27 | vinorelbine- | 3 |
28 | 2,618 | 2 |
29 | 22-kda | 2 |
30 | 32μg/ml | 2 |
31 | 4-cyanophenolate | 2 |
32 | 66kda | 2 |
33 | arg129 | 2 |
34 | degree-minutes | 2 |
35 | doctor- | 2 |
36 | gemfibrizol | 2 |
37 | high-signal | 2 |
38 | igs-9 | 2 |
39 | impetiginized | 2 |
40 | lavendin | 2 |
41 | medium-range | 2 |
42 | pre-incident | 2 |
43 | pvax1-g-ltb | 2 |
44 | retch | 2 |
45 | tar/nicotine | 2 |
46 | vacuum- | 2 |
47 | 'subendocardial | 1 |
48 | 1-to-10 | 1 |
49 | 2-low | 1 |
50 | 3-high | 1 |
51 | best-imagined | 1 |
52 | betamethasone-17α-valerate-induced | 1 |
53 | haloperidol-equivalent | 1 |
54 | midequipotency | 1 |
55 | six-divided | 1 |
56 | tps-calculated | 1 |
57 | treated/untreated | 1 |
1 | 'subendocardial | 1 |
2 | 0.4±0.8 | 3 |
3 | 1-to-10 | 1 |
4 | 15μm | 6 |
5 | 2,618 | 2 |
6 | 2-low | 1 |
7 | 22-kda | 2 |
8 | 3-high | 1 |
9 | 32μg/ml | 2 |
10 | 4-cyanophenolate | 2 |
11 | 5/200 | 16 |
12 | 66kda | 2 |
13 | allevyn™ | 6 |
14 | arg129 | 2 |
15 | as≥3 | 3 |
16 | batyl | 3 |
17 | best-imagined | 1 |
18 | betamethasone-17α-valerate-induced | 1 |
19 | cyca | 3 |
20 | degree-minutes | 2 |
21 | difficult-to-revert | 3 |
22 | doctor- | 2 |
23 | franc | 3 |
24 | gemfibrizol | 2 |
25 | haloperidol-equivalent | 1 |
26 | high-moderate | 4 |
27 | high-signal | 2 |
28 | hyposmic | 5 |
29 | igs-9 | 2 |
30 | impetiginized | 2 |
31 | lancinating | 8 |
32 | lavendin | 2 |
33 | medium-range | 2 |
34 | medium/high | 15 |
35 | midequipotency | 1 |
36 | moderate | 21,087 |
37 | moderate-level | 12 |
38 | moderate-to-light | 3 |
39 | moderately-severe | 11 |
40 | neuroimage | 3 |
41 | ni2+ | 4 |
42 | one-grade | 3 |
43 | over-response | 3 |
44 | pheromonal | 4 |
45 | pre-incident | 2 |
46 | pvax1-g-ltb | 2 |
47 | retch | 2 |
48 | six-divided | 1 |
49 | t3a | 5 |
50 | t4lhyp | 6 |
51 | tar/nicotine | 2 |
52 | tps-calculated | 1 |
53 | treated/untreated | 1 |
54 | troncular | 4 |
55 | vacuum- | 2 |
56 | very-low- | 5 |
57 | vinorelbine- | 3 |
1 | ni2+ | 4 |
2 | vinorelbine- | 3 |
3 | vacuum- | 2 |
4 | doctor- | 2 |
5 | very-low- | 5 |
6 | 5/200 | 16 |
7 | 1-to-10 | 1 |
8 | as≥3 | 3 |
9 | 0.4±0.8 | 3 |
10 | 2,618 | 2 |
11 | igs-9 | 2 |
12 | arg129 | 2 |
13 | t3a | 5 |
14 | cyca | 3 |
15 | 22-kda | 2 |
16 | 66kda | 2 |
17 | pvax1-g-ltb | 2 |
18 | hyposmic | 5 |
19 | franc | 3 |
20 | betamethasone-17α-valerate-induced | 1 |
21 | six-divided | 1 |
22 | best-imagined | 1 |
23 | treated/untreated | 1 |
24 | tps-calculated | 1 |
25 | impetiginized | 2 |
26 | one-grade | 3 |
27 | neuroimage | 3 |
28 | medium-range | 2 |
29 | tar/nicotine | 2 |
30 | moderately-severe | 11 |
31 | over-response | 3 |
32 | 4-cyanophenolate | 2 |
33 | moderate | 21,087 |
34 | high-moderate | 4 |
35 | lancinating | 8 |
36 | retch | 2 |
37 | 3-high | 1 |
38 | medium/high | 15 |
39 | 'subendocardial | 1 |
40 | high-signal | 2 |
41 | pheromonal | 4 |
42 | moderate-level | 12 |
43 | 32μg/ml | 2 |
44 | gemfibrizol | 2 |
45 | batyl | 3 |
46 | 15μm | 6 |
47 | lavendin | 2 |
48 | t4lhyp | 6 |
49 | troncular | 4 |
50 | degree-minutes | 2 |
51 | moderate-to-light | 3 |
52 | pre-incident | 2 |
53 | haloperidol-equivalent | 1 |
54 | difficult-to-revert | 3 |
55 | 2-low | 1 |
56 | midequipotency | 1 |
57 | allevyn™ | 6 |